Smith+Nephew announces its CORIOGRAPH Pre-Op Planning and Modeling Services is now cleared for total hip arthroplasty by the United States Food and Drug Administration. Exclusively for users of the CORI Surgical System, this innovative planning software allows for use of either X-rays or CT scans for planning and modeling, enabling surgeons to make a patient-specific plan for the best possible outcome. The first procedures using CORIOGRAPH Pre-Op Planning and Modeling Services for Hip with RI.HIP solutions were recently completed by Dr. George Haidukewych, Surgeon in Chief and Academic Chairman at Orlando Health Jewett Orthopedic Institute in Orlando, FL.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on SNN:
- Smith & Nephew’s Shareholding Shift: BlackRock’s Increased Stake
- Smith & Nephew receives 510(k) clearance for AETOS Stemless
- Smith & Nephew Announces Change in Major Holdings
- Smith & Nephew Reports Change in BlackRock’s Voting Rights
- Smith & Nephew Director Invests in Company Shares
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
